Tradestie Institutional Equity Comparison Engine

NPCE vs BMRA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

NPCE Overall Edge

NPCE Captures Institutional Edge (3โ€“1 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Neuropace, Inc. Common Stock (NPCE) driven by superior Valuation, Growth & Margin, Momentum & Technical while BMRA counters with relative strength in Options & Structure. Fundamentally, NPCE trades at 138.9x Forward P/E with -11.3% operating margin (-15.5% YoY revenue) versus BMRA at N/M Forward P/E and -125.2% operating margin (-8.3% YoY). In options structure, NPCE sits in BREAKDOWN (45th %ile IV; Dealer Gamma Walls on Pro) against BMRA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner NPCE
NPCE 138.9x vs BMRA N/M Fwd P/E
Growth & Margin Winner NPCE
Op Margin -11.3% vs -125.2% ยท YoY -15.5% vs -8.3%
Momentum & Technical Winner NPCE
1Y -39.4% vs -46.9% ยท 52W Pos 16% vs 4%
Options & Structure Winner BMRA
BREAKDOWN (45th %ile IV) vs UNCLASSIFIED (N/A IV)
NPCE NASDAQ
Neuropace, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$7.76
+2.71% 1D
Market Cap $412.6M
1M Return -36.56%
1Y Return -39.38%
Forward P/E 138.9x
Unified AI Score
41.0 / 100 SELL
Tech 25.0 Fund 44.0 Flow 68.0 Mom 40.0
BMRA NASDAQ
Biomerica Inc
In Vitro & In Vivo Diagnostic Substances
$1.33
-2.32% 1D
Market Cap $6.0M
1M Return -28.19%
1Y Return -46.86%
Forward P/E N/M
Unified AI Score
44.5 / 100 HOLD
Tech 40.0 Fund 47.0 Flow 50.0 Mom 44.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: NPCE -39.38% BMRA -46.86% Spread: +7.48 pp (NPCE Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period NPCE Revenue BMRA Revenue NPCE Op. Margin BMRA Op. Margin Margin Edge
FY2019 N/A $10M N/A -46.4% BMRA
FY2020 $40M $10M -31.7% -41.0% NPCE
FY2021 $50M $10M -52.5% -104.2% NPCE
FY2022 $50M $20M -89.6% -24.0% BMRA
FY2023 $70M $10M -41.5% -135.3% NPCE
FY2024 $80M $10M -27.1% -117.6% NPCE
FY2025 $100M $10M -16.3% -96.7% NPCE
FY2026 N/A $0M N/A -119.5% BMRA

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: NPCE (7) vs BMRA (3)
Institutional Metric NPCE BMRA Criterion Row Winner
Market Capitalization Scale $412.6M $6.0M Larger Scale NPCE
Trailing P/E Ratio Valuation 138.9x N/M Lower Multiple NPCE
Forward P/E Ratio Valuation 138.9x N/M Lower Multiple NPCE
Revenue Growth (YoY) Growth -15.5% -8.3% Higher Growth BMRA
Operating Margin (TTM) Profitability -11.3% -125.2% Higher Margin NPCE
Net Profit Margin Profitability -18.4% -115.5% Higher Margin NPCE
Return on Equity (ROE) Capital Efficiency -106.5% -113.8% Higher ROE NPCE
52-Week Range Position Momentum 16% ($5โ€“$20) 4% ($1โ€“$3) Stronger Trend NPCE
Beta / 30D Volatility Risk Regime 1.32ฮฒ ยท 139% Vol 0.67ฮฒ ยท 62% Vol Lower Realized Risk BMRA
Unified Institutional Score Composite Signal 41.0 / 100 (SELL) 44.5 / 100 (HOLD) Higher Composite BMRA

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full NPCE vs BMRA Buy Guide
NPCE BREAKDOWN
133d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 45th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live NPCE Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
BMRA UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live BMRA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither NPCE nor BMRA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.